Flightless-I Blocks p62-Mediated Recognition of LC3 to Impede Selective Autophagy and Promote Breast Cancer Progression
Authors:
Open Access
- 1 September 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 78 (17) , 4853-4864
Abstract
P62 is a receptor that facilitates selective autophagy by interacting simultaneously with cargoes and LC3 protein on the autophagosome to maintain cellular homeostasis. However, the regulatory mechanism(s) behind this process and its association with breast cancer remain to be elucidated. Here, we report that Flightless-I (FliI), a novel p62-interacting protein, promotes breast cancer progression by impeding selective autophagy. FliI was highly expressed in clinical breast cancer samples, and heterozygous deletion of FliI retarded the development of mammary tumors in PyVT mice. FliI induced p62-recruited cargoes into Triton X-100 insoluble fractions (TI) to form aggregates, thereby blocking p62 recognition of LC3 and hindering p62-dependent selective autophagy. This function of Flil was reinforced by Akt-mediated phosphorylation at Ser436 and inhibited by phosphorylation of Ulk1 at Ser64. Obstruction of autophagic clearance of p62-recruited cargoes by FliI was associated with the accumulation of oxidative damage on proteins and DNA, which could contribute to the development of cancer. Heterozygous knockout of FliI facilitated selectively autophagic clearance of aggregates, abatement of ROS levels, and protein oxidative damage, ultimately retarding mammary cancer progression. In clinical breast cancer samples, Akt-mediated phosphorylation of FliI at Ser436 negatively correlated with long-term prognosis, while Ulk1-induced FliI phosphorylation at Ser64 positively correlated with clinical outcome. Together, this work demonstrates that FliI functions as a checkpoint protein for selective autophagy in the crosstalk between FliI and p62-recruited cargoes, and its phosphorylation may serve as a prognostic marker for breast cancer. Significance: Flightless-I functions as a checkpoint protein for selective autophagy by interacting with p62 to block its recognition of LC3, leading to tumorigenesis in breast cancer.Cancer Res; 78(17); 4853–64. ©2018 AACR.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (31230019, 2014CB910602, U1405224)
- National Natural Science Foundation of China (81472425, 81672695, 2017YFA0504502)
- Fundamental Research Funds for the Central Universities, China (20720150050)
- Project 211 (B12001)
- State Key Laboratory of Cellular Stress Biology, Xiamen University (SKLCSB2016KF001)
This publication has 44 references indexed in Scilit:
- Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective AutophagyMolecular Cell, 2013
- Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patientsBreast Cancer Research and Treatment, 2012
- The role of the Atg1/ULK1 complex in autophagy regulationCurrent Opinion in Cell Biology, 2010
- The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1Nature Cell Biology, 2010
- A Role for Ubiquitin in Selective AutophagyMolecular Cell, 2009
- Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activityJournal of Cell Biology, 2008
- Fission and selective fusion govern mitochondrial segregation and elimination by autophagyThe EMBO Journal, 2008
- The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive diseaseEndocrine-Related Cancer, 2007
- MOLECULAR ASPECTS OF ARSENIC STRESSJournal of Toxicology and Environmental Health, Part B, 2000
- Are the conserved sequences in segment 1 of gelsolin important for binding actin?Journal of Cell Biology, 1992